Bullet Biotechnology

About:

Bullet Biotechnology is biotech company developing products that improve a patient's immune system to fight diseases.

Website: http://www.bulletbio.com

Twitter/X: wpquinn

Description:

Bullet Biotechnology is an innovative biotech company developing powerful products that will train a patient's own immune system to fight disease. Using our proprietary protein nanoparticles, we create powerful immunotherapies to target cancer. Their initial product dramatically improves response rates to checkpoint inhibitors such as anti-PD1 and anti-CTLA4 and will be developed for solid tumors. Bullet Biotech’s experienced management team is taking a practical approach to building and realizing value for patients and investors.

Total Funding Amount:

$2.18M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)bulletbio.com

Founders:

Willie Quinn

Number of Employees:

1-10

Last Funding Date:

2016-06-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai